Frontiers

Leveraging transcriptomic, DNA methylation, and molecular alteration data to optimize the classification of IDH-mutant gliomas for therapy selection

L. Nicolas Gonzalez Castro 1,2,3,4,5,6* The fact that the grading of IDH-mutant glioma according to the current WHO CNS tumor classification does not help predict what patients are likely to benefit ...
Frontiers

Hotspot gene mutations and treatment response in myelodysplastic syndromes (MDS): predictive biomarkers and targeted strategies

1 Department of Hematology, Center for Hematologic Diseases of Chinese PLA, The 940th Hospital of Joint Logistics Support force of Chinese People’s Liberation Army (Lanzhou Military Command General ...